Informações:
Falhas:
ID
20622
Descrição
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02202564
Link
https://clinicaltrials.gov/show/NCT02202564
Palavras-chave
Versões (1)
- 07/03/2017 07/03/2017 -
Transferido a
7 de março de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Liver Cancer NCT02202564
Eligibility Liver Cancer NCT02202564
- StudyEvent: Eligibility
Similar models
Eligibility Liver Cancer NCT02202564
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
age, gender
Item
18～70 years of age (male and female).
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
hepatocellular carcinoma, liver transplantation
Item
clinical diagnosis of advanced hepatocellular carcinoma who could accept liver transplantation
boolean
C0278774 (UMLS CUI [1])
C0023911 (UMLS CUI [2])
C0023911 (UMLS CUI [2])
localized unresectable adult primary liver cancer | Secondary malignant neoplasm of lung | Secondary malignant neoplasm of bone | Tumor extent of invasion; Structure of branch of portal vein
Item
patients who had unresectable hcc >5 cm and no metastasis in lungs and bones were eligible to participate in this study. tumor involvement in the intrahepatic and extrahepatic portal branches was not considered to be an exclusion criterion.
boolean
C0278773 (UMLS CUI [1])
C0475440 (UMLS CUI [2])
C0153676 (UMLS CUI [3])
C0153690 (UMLS CUI [4])
C1269793 (UMLS CUI [5,1])
C0226736 (UMLS CUI [5,2])
C0475440 (UMLS CUI [2])
C0153676 (UMLS CUI [3])
C0153690 (UMLS CUI [4])
C1269793 (UMLS CUI [5,1])
C0226736 (UMLS CUI [5,2])
Prior Chemotherapy | prior radiation therapy | Prior Therapy; Targeted cancer therapy | Prior Therapy; Biological Response Modifier Therapy
Item
no prior chemotherapy, radiation therapy, targeted therapy or other kind of biological treatment within 4 weeks.
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C3854476 (UMLS CUI [3,2])
C1514463 (UMLS CUI [4,1])
C0005527 (UMLS CUI [4,2])
C0279134 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C3854476 (UMLS CUI [3,2])
C1514463 (UMLS CUI [4,1])
C0005527 (UMLS CUI [4,2])
informed consent
Item
provide written informed consent
boolean
C0021430 (UMLS CUI [1])
metastasis in lungs and bones
Item
metastasis in lungs and bones
boolean
C0153676 (UMLS CUI [1])
C0153690 (UMLS CUI [2])
C0153690 (UMLS CUI [2])
invasion in main vescular
Item
invasion in main vescular.
boolean
C0521157 (UMLS CUI [1])
contraindications of liver transplantation
Item
contraindications of liver transplantation
boolean
C1301624 (UMLS CUI [1,1])
C0023911 (UMLS CUI [1,2])
C0023911 (UMLS CUI [1,2])
contraindications of operation of other organ system
Item
contraindications of operation of other organ system
boolean
C1301624 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,2])
hypersensitivity to adenovirus or gcv
Item
hypersensitivity to adenovirus, gcv or similar drugs
boolean
C0020517 (UMLS CUI [1,1])
C0001483 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0017066 (UMLS CUI [2,2])
C0001483 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0017066 (UMLS CUI [2,2])
accept clinical trials of other drugs
Item
accept clinical trials of other drugs
boolean
C0008976 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
immunological deficit
Item
immunological deficit
boolean
C0021053 (UMLS CUI [1])
pregnancy
Item
active pregnancy
boolean
C0032961 (UMLS CUI [1])
informed consent
Item
unable or unwilling to sign informed consents
boolean
C0021430 (UMLS CUI [1])